Palvella Therapeutics (PVLA) Exchange Rate Effect (2016 - 2026)
Palvella Therapeutics has reported Exchange Rate Effect over the past 9 years, most recently at $1.9 million for Q4 2022.
- Quarterly Exchange Rate Effect rose 315.39% to $1.9 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$5.2 million through Dec 2022, down 62.23% year-over-year, with the annual reading at $46000.0 for FY2025, 1433.33% up from the prior year.
- Exchange Rate Effect was $1.9 million for Q4 2022 at Palvella Therapeutics, up from -$2.8 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $2.2 million in Q3 2020 and troughed at -$3.3 million in Q2 2022.
- The 5-year median for Exchange Rate Effect is -$378000.0 (2018), against an average of -$367250.0.
- Year-over-year, Exchange Rate Effect soared 515.81% in 2020 and then plummeted 10268.75% in 2022.
- A 5-year view of Exchange Rate Effect shows it stood at -$347000.0 in 2018, then surged by 210.09% to $382000.0 in 2019, then soared by 433.25% to $2.0 million in 2020, then plummeted by 144.33% to -$903000.0 in 2021, then surged by 315.39% to $1.9 million in 2022.
- Per Business Quant, the three most recent readings for PVLA's Exchange Rate Effect are $1.9 million (Q4 2022), -$2.8 million (Q3 2022), and -$3.3 million (Q2 2022).